Medical Therapy of Glaucoma


The overwhelming majority of eye disease is treated with eye drops, and undefeated eye disease management needs a comprehensive understanding of topical ocular medical care. The mucous membrane cul-de-sac may be a distinctive pharmacokinetic surroundings and provides several challenges to effective topical medical care. The principles reviewed here are often applied to subsequent chapters managing every specific drug category. In choosing the best medication, practitioners ought to think about the properties of medicine (e.g., efficiency and efficacy), and also the best dosing formulation (e.g., solution, suspension, gel). The medical man ought to conjointly make sure that the patient receives education regarding the correct instillation of medicines, and also the importance of adhering to the prescribed programme. Finally, with continued changes in health care management and pharmaceutical developments, problems with generic versus branded medication area unit having AN increasing impact on chronic, topical eye disease medical care.

  • Ocular Medications
  • Adrenergic Agonists

Related Conference of Medical Therapy of Glaucoma

September 14-15, 2026

40th European Ophthalmology Congress

Rome, Italy
September 14-15, 2026

7th World Congress on Ophthalmology and Vision Science

Rome, Italy
September 14-15, 2026

6th European Congress on Laser, Optics and Photonics

Barcelona, Spain
September 21-22, 2026

21st International Conference on Ophthalmology and Vision Science

Amsterdam, Netherlands
October 05-06, 2026

26th Global Ophthalmologists Annual Meeting

Rome, Italy
October 15-16, 2026

8th International Conference on Optometry

Paris, France
December 03-04, 2026

9th International Eye and Vision Congress

Madrid, Spain

Medical Therapy of Glaucoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in